Clinical outcome and incidence of inhibitor development in severe hemophilia patients receiving low-dose prophylaxis: a 3-year follow-up study in Senegal, West Africa

INTRODUCTION: In Africa, where access to diagnosis and treatment of hemophilia is the lowest in the world, prophylaxis is rarely used in preference to on-demand treatment. There are limited data of prophylaxis treatment from sub-Saharan Africa. The aim of this study was to evaluate clinical outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Touré, Sokhna Aïssatou, Seck, Moussa, Sy, Diariatou, Senghor, Alioune Badara, Faye, Blaise Felix, Diop, Saliou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433309/
https://www.ncbi.nlm.nih.gov/pubmed/35606318
http://dx.doi.org/10.1016/j.htct.2022.04.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433309/
https://www.ncbi.nlm.nih.gov/pubmed/35606318
http://dx.doi.org/10.1016/j.htct.2022.04.004

Ejemplares similares